FDA无菌生产指南 中英文对照版.doc

PAGE Copyright SCI Version 1 Translated from / 译自： Guidance for Industry Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice 行业指南 无菌加工生产的无菌药品 —现行的生产质量管理规范(cGMP） U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Office of Regulatory Affairs (ORA) September 2004 Pharmaceutical CGMPs Copyright SCI Version 1 Guidance for Industry Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice Additional copies are available from: Office of Training and Communication Division of Drug Information, HFD-240 Center for Drug Evaluation and Research Food and Drug Administration 5600 Fishers Lane Rockville, MD 20857 (Tel) 301-827-4573 /cder/guidance/index.htm or Office of Communication, Training and Manufacturers Assistance, HFM-40 Center for Biologics Evaluation and Research Food and Drug Administration 1401 Rockville Pike, Rockville, MD 20852-1448 /cber/guidelines.htm. (Tel) Voice Information System at 800-835-4709 or 301-827-1800 U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Office of Regulatory affairs (ORA) September 2004 Pharmaceutical CGMPs Contains Nonbinding Recommendations Copyright SCI Version 1 TABLE OF CONTENTS TOC \o 1-3 I. Introduction PAGEREF _To\h 1 简介 II. Background PAGEREF _To\h 2 背景 A. Regulatory Framework PAGEREF _To\h 3 法规架构 B. Technical Framework PAGEREF _To\h 3 技术架构 III. Scope PAGEREF _To\h 4 适用范围 IV. BUILDINGS AND FACILITIES PAGEREF _To\h 5 厂房和建筑 A. Critical Area – Class 100 (ISO 5) PAGEREF _To\h 5 关键区域– 100级 (ISO 5) B. Supporting Clean Areas PAGEREF _To\h 5 辅助洁净区域 C. Clean Area Separation PAGEREF _To\h 5 净化区的隔离 D.